Single Dose of Trastuzumab Kick Starts Immune Response in Certain Breast Cancers

Single Dose of Trastuzumab Kick Starts Immune Response in Certain Breast Cancers

“Our study showed, for the first time, that the immune-cell–activating properties of trastuzumab are likely related to the subtypes of breast cancer,” Varadan said. “Knowing this can inform future trials studying the usefulness of adding immunotherapy

(Visited 4 times, 1 visits today)
1
Like
Save

Comments

Comments are disabled for this post.